BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18751977)

  • 1. Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.
    Tourkova IL; Shurin GV; Ferrone S; Shurin MR
    Cancer Immunol Immunother; 2009 Apr; 58(4):567-74. PubMed ID: 18751977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides.
    Tourkova IL; Shurin GV; Chatta GS; Perez L; Finke J; Whiteside TL; Ferrone S; Shurin MR
    J Immunol; 2005 Sep; 175(5):3045-52. PubMed ID: 16116192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells.
    Seo MJ; Kim GR; Son YM; Yang DC; Chu H; Min TS; Jung ID; Park YM; Han SH; Yun CH
    Mol Immunol; 2011 Sep; 48(15-16):1744-52. PubMed ID: 21632112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
    Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
    J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of defective antigen processing in human prostate cancer.
    Sanda MG; Restifo NP; Walsh JC; Kawakami Y; Nelson WG; Pardoll DM; Simons JW
    J Natl Cancer Inst; 1995 Feb; 87(4):280-5. PubMed ID: 7707419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency.
    Nishimoto KP; Tseng SY; Lebkowski JS; Reddy A
    Regen Med; 2011 May; 6(3):303-18. PubMed ID: 21548736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells.
    Mattei F; Schiavoni G; Borghi P; Venditti M; Canini I; Sestili P; Pietraforte I; Morse HC; Ramoni C; Belardelli F; Gabriele L
    Blood; 2006 Jul; 108(2):609-17. PubMed ID: 16569763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
    Whiteside TL; Stanson J; Shurin MR; Ferrone S
    J Immunol; 2004 Aug; 173(3):1526-34. PubMed ID: 15265880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell biology and its role in tumor immunotherapy.
    Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
    J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells.
    Utsugi-Kobukai S; Fujimaki H; Hotta C; Nakazawa M; Minami M
    Immunol Lett; 2003 Oct; 89(2-3):125-31. PubMed ID: 14556969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.
    Schnurr M; Chen Q; Shin A; Chen W; Toy T; Jenderek C; Green S; Miloradovic L; Drane D; Davis ID; Villadangos J; Shortman K; Maraskovsky E; Cebon J
    Blood; 2005 Mar; 105(6):2465-72. PubMed ID: 15546948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.
    Shurin GV; Shurin MR; Bykovskaia S; Shogan J; Lotze MT; Barksdale EM
    Cancer Res; 2001 Jan; 61(1):363-9. PubMed ID: 11196188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
    Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
    J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.
    Liao YP; Wang CC; Butterfield LH; Economou JS; Ribas A; Meng WS; Iwamoto KS; McBride WH
    J Immunol; 2004 Aug; 173(4):2462-9. PubMed ID: 15294960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.